Drug intelligence / Profile preview

13C-pyruvate + 13C-lactate + dichloroacetate

Development stage
Preclinical
Lead developer
GE Healthcare
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous, Oral
01

Overview

This is a combination of three agents: - **13C-pyruvate** and **13C-lactate** are stable isotope-labeled forms of pyruvate and lactate, commonly used as metabolic tracers in research to study cellular metabolism and flux through glycolytic and mitochondrial pathways. - **Dichloroacetate (DCA)** is a small molecule inhibitor of pyruvate dehydrogenase kinase (PDK). By inhibiting PDKs, DCA activates the pyruvate dehydrogenase complex (PDH), promoting the conversion of pyruvate to acetyl-CoA rather than lactate. This shifts cellular metabolism from anaerobic glycolysis toward aerobic oxidation. DCA has been studied for its effects on energy metabolism in conditions such as sepsis, cancer, metabolic disorders, and platelet function[1][2][4]. The combination may be used experimentally to trace metabolic pathways using labeled substrates while pharmacologically modulating PDH activity with DCA.

Other names
13C-pyruvate13C-lactatedichloroacetateDCA
02

Targets

PDK (Pyruvate dehydrogenase kinase isoform 1)

Beyond the preview

Go deeper on 13C-pyruvate + 13C-lactate + dichloroacetate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 13C-pyruvate + 13C-lactate + dichloroacetate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call